HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:
Consumer Legislation Health

Health Market News: DXM Sales Age-Restriction Bill Filed, E-Cigarettes Top NRTs In UK Trial

  • News

Executive Summary

Resp. Matsui, Johnson again introduce bill for national age-18 requirement for OTC DXM sales; E-Cigarettes top NRTs for smoking cessation efficacy in UK trial.

Table

View full table

Advertisement

Related Content

HBW Insight
Using NRT Products In Combination Increases Chances Of Quitting Smoking, Cochrane Review Finds
HBW Insight
Health And Wellness Industry News: Restoring Access Bill Introduced, Another Dietary Fiber Meets FDA Definition, More
HBW Insight
OTCs Under Threat In Europe: Calls To Reverse-Switch Codeine And Others In Poland And Ireland
HBW Insight
E-Cigarettes' Appeal For Smoking Cessation Cooled By Risk Questions
HBW Insight
States With Age Restriction On OTC DXM Sales Number 17 – And Counting
HBW Insight
Sales of Drug-Spiked Nicotine Could Sink E-Cigarettes' Smoking Cessation Chances
Pink Sheet
Emotional Backdrop Smolders As FDA Reviews Smoking Cessation Category

Topics

Advertisement
Tags:
Consumer Legislation Health
UsernamePublicRestriction

Register

RS148486

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By